Hence, we sequenced all KLK6 exons and the 5′-flanking region for ovarian tumours with various KLK6 levels to determine if genetic aberrations may account for the upregulation of KLK6 in ovarian cancer. This evidence concerns the gene KLK6 and ovarian neoplasm.